Rhythm Biosciences Limited (ASX:RHY)
Australia flag Australia · Delayed Price · Currency is AUD
0.200
+0.015 (8.11%)
At close: Mar 9, 2026

Rhythm Biosciences Market Cap

Rhythm Biosciences has a market cap or net worth of 65.60 million as of March 9, 2026. Its market cap has increased by 159.89% in one year.

Market Cap
65.60M
Enterprise Value
64.13M
Revenue
1.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20

Market Cap Chart

Since December 7, 2017, Rhythm Biosciences's market cap has increased from 32.74M to 65.60M, an increase of 100.33%. That is a compound annual growth rate of 8.79%.

History

DateMarket Cap% Change
Mar 6, 202660.66M37.80%
Dec 31, 202544.02M78.41%
Dec 31, 202424.67M-17.35%
Dec 29, 202329.85M-86.11%
Dec 30, 2022215.00M-33.62%
Dec 31, 2021323.86M83.69%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Cryosite 58.57M
Microba Life Sciences 49.93M
INOVIQ 46.46M
BCAL Diagnostics 44.17M
Genetic Signatures 21.58M
Monash IVF Group 257.16M
Imagion Biosystems 9.81M
Australian Clinical Labs 416.48M
Market Cap Rankings